141 related articles for article (PubMed ID: 18091760)
1. High-risk molecules or insufficient scientific data?
Mignot A
Clin Pharmacol Ther; 2008 Feb; 83(2):365-7. PubMed ID: 18091760
[TBL] [Abstract][Full Text] [Related]
2. Missing results might have rung warning bell over trial drug.
Pearson H
Nature; 2006 Oct; 443(7113):730-1. PubMed ID: 17051171
[No Abstract] [Full Text] [Related]
3. The impact of escalating regulatory requirements on the conduct of clinical research.
Gordon BG; Kessinger A; Mann SL; Prentice ED
Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
[TBL] [Abstract][Full Text] [Related]
4. Safety assessment and dose selection for first-in-human clinical trials with immunomodulatory monoclonal antibodies.
Muller PY; Brennan FR
Clin Pharmacol Ther; 2009 Mar; 85(3):247-58. PubMed ID: 19177065
[TBL] [Abstract][Full Text] [Related]
5. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
[TBL] [Abstract][Full Text] [Related]
6. A study of warning letters issued to clinical investigators by the United States Food and Drug Administration.
Bramstedt KA
Clin Invest Med; 2004 Jun; 27(3):129-34. PubMed ID: 15305804
[TBL] [Abstract][Full Text] [Related]
7. Preclinical and clinical safety of monoclonal antibodies.
Tabrizi MA; Roskos LK
Drug Discov Today; 2007 Jul; 12(13-14):540-7. PubMed ID: 17631248
[TBL] [Abstract][Full Text] [Related]
8. From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials.
Heemskerk J; Tobin AJ; Ravina B
Nat Neurosci; 2002 Nov; 5 Suppl():1027-9. PubMed ID: 12403977
[No Abstract] [Full Text] [Related]
9. Guidelines for clinical research in developing countries.
Vray M; Simon F; Bompart F;
Therapie; 2007; 62(3):217-27. PubMed ID: 17803889
[TBL] [Abstract][Full Text] [Related]
10. Conduct and reporting of clinical research.
Liu JL; Altman DG
Science; 2005 Apr; 308(5719):201-2. PubMed ID: 15821071
[No Abstract] [Full Text] [Related]
11. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
Grienenberger A
J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
[TBL] [Abstract][Full Text] [Related]
12. London's disastrous drug trial has serious side effects for research.
Wadman M
Nature; 2006 Mar; 440(7083):388-9. PubMed ID: 16554763
[No Abstract] [Full Text] [Related]
13. Clinical trial registration.
Brubaker L
Neurourol Urodyn; 2007; 26(2):147. PubMed ID: 17354253
[No Abstract] [Full Text] [Related]
14. Consider drug efficacy before first-in-human trials.
Kimmelman J; Federico C
Nature; 2017 Jan; 542(7639):25-27. PubMed ID: 28150789
[No Abstract] [Full Text] [Related]
15. First-in-Man (FIM) clinical trials post-TeGenero: a review of the impact of the TeGenero trial on the design, conduct, and ethics of FIM trials.
Nada A; Somberg J
Am J Ther; 2007; 14(6):594-604. PubMed ID: 18090886
[TBL] [Abstract][Full Text] [Related]
16. Hidden risks associated with clinical trials in developing countries.
Lorenzo C; Garrafa V; Solbakk JH; Vidal S
J Med Ethics; 2010 Feb; 36(2):111-5. PubMed ID: 20133407
[TBL] [Abstract][Full Text] [Related]
17. [Fundamental principles of clinical trials].
Skarke C; Geisslinger G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):401-7. PubMed ID: 15830250
[TBL] [Abstract][Full Text] [Related]
18. Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo Nordisk.
Weiskopf RB;
Acad Emerg Med; 2007 Apr; 14(4):e71-3. PubMed ID: 17322571
[No Abstract] [Full Text] [Related]
19. [From molecule to medicine--drug development].
Bruhn C
Dtsch Med Wochenschr; 2010 Feb; 135(6):p5. PubMed ID: 20151355
[No Abstract] [Full Text] [Related]
20. Stem-cell-derived products: an FDA update.
Moos M
Trends Pharmacol Sci; 2008 Dec; 29(12):591-3. PubMed ID: 18937983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
